Skip to content

Determination of Drugs and Their Metabolites in Hospitalized Patients

Determination of Drugs and Their Metabolites in Hospitalized Patients

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01702545
Enrollment
1000
Registered
2012-10-08
Start date
2012-08-31
Completion date
2021-12-31
Last updated
2020-09-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neoplasms

Brief summary

The current state of knowledge on the concentration of drugs and their metabolites in the individual human body is not satisfying concerning the question about behavior of drugs in the human body, taking into account individual patient factors such as age, weight and organ dysfunctions. This projects deals with the question of drug levels in the blood of hospitalized patients. The aim of this study is to extend the knowledge about the behavior of drugs in the human body significantly, for the safety and benefit of future patients. This also includes to establish a relationship between drug levels in patients and the desired and undesired effects of a drug. As a result, the future perspective is to find the optimal dose for the individual patient by measuring the blood concentration of a drug.

Detailed description

The primary goal of the study is to gain an overview of the plasma concentrations of relevant drugs which occur in different patient populations and to what extent they are consistent with those concentrations described in the literature. If the expectation is confirmed, that a significant heterogeneity in the plasma concentrations of these patients exists, the investigators will try to find influencing factors for this circumstance on the basis of routine clinical parameters (height, weight, renal function, concomitant medications, etc.). Ultimately, this project will identify substances with a high interindividual variability in plasma levels, where drug monitoring might be suggested.

Interventions

None listed

Sponsors

Klinikum Nürnberg
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 99 Years
Healthy volunteers
No

Inclusion criteria

* legal capacity

Exclusion criteria

* severe anemia

Design outcomes

Primary

MeasureTime frame
Plasma concentrations [ng/mL] of various drugs at different timepointsup to five years

Countries

Germany

Contacts

Primary ContactMartin Wilhelm, Prof. Dr.
martin.wilhelm@klinikum-nuernberg.de00499113983050
Backup ContactMartin Wilhelm, Prof Dr
martin.wilhelm@klinikum-nuernberg.de00499113983050

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026